Jejunum Regeneration – Renewal of the Small Intestinal Lining

What is the Jejunum?

The jejunum is the middle section of the small intestine, located between the duodenum and the ileum. It is the primary site of nutrient absorption in the human body, where carbohydrates, proteins, fats, vitamins, and minerals are taken up into the bloodstream. The lining of the jejunum is covered with finger-like projections called villi and even smaller microvilli, which dramatically increase the absorptive surface area and enable efficient nutrient uptake.

What is Jejunum Regeneration?

Jejunum regeneration describes the biological process by which damaged or diseased tissue of the jejunum is renewed and functionally restored. The small intestinal mucosa possesses a remarkable capacity for self-renewal: epithelial cells (enterocytes) lining the villi are continuously replenished from crypt stem cells (Lgr5+ stem cells) located in the intestinal crypts. Under normal conditions, the entire intestinal epithelium is completely renewed every three to five days.

Causes of Impaired Jejunum Regeneration

Various diseases and factors can compromise the regenerative capacity of the jejunum:

• Celiac disease: The gluten-triggered immune response causes villous atrophy and mucosal damage.
• Crohn's disease: A chronic inflammatory bowel disease that can affect the jejunum and inhibit regeneration.
• Short bowel syndrome: Following surgical removal of portions of the small intestine, the remaining jejunum must regenerate and adapt compensatorily.
• Radiation enteritis: Radiation damage to the intestinal mucosa following abdominal radiotherapy.
• Chemotherapy: Cytostatic agents can damage the rapidly dividing stem cells in the intestine, delaying regeneration.
• Infections: Bacterial or viral gastroenteritis can damage the small intestinal mucosa.
• Malnutrition: Deficiencies in essential nutrients impair cell division and tissue healing.

Mechanisms of Jejunum Regeneration

Stem Cell-Based Renewal

Jejunum regeneration is primarily driven by intestinal stem cells located in the crypts of Lieberkuhn. These stem cells continuously divide and produce new epithelial cells that migrate up the villi, replacing shed cells. The Wnt signaling pathway and the Notch signaling pathway play central regulatory roles in this process.

Mucosal Adaptation

In short bowel syndrome, the remaining jejunum can undergo structural and functional adaptation: villi become taller, crypts become deeper, and the absorptive surface area increases. This adaptive process is driven by intestinal growth factors such as GLP-2 (glucagon-like peptide-2), EGF (epidermal growth factor), and IGF-1.

Inflammation Regulation

A balanced immune response is critical for successful regeneration. Excessive inflammatory reactions inhibit healing, while a controlled immune response promotes tissue repair.

Diagnosis of Regenerative Disorders

Assessment of the jejunal mucosa and its regeneration involves several diagnostic approaches:

• Endoscopy with biopsy: Direct visualization of the mucosal architecture and histological analysis of tissue samples.
• Capsule endoscopy: Imaging of the entire small intestine using a swallowable camera capsule.
• Blood tests: Measurement of absorption parameters (e.g., albumin, vitamins, electrolytes) to assess intestinal function.
• Imaging: MRI or CT of the abdomen to detect structural abnormalities.

Therapeutic Approaches to Promote Jejunum Regeneration

Nutritional Therapy

Tailored enteral nutrition (via the gastrointestinal tract) is essential for maintaining stem cell activity and promoting regeneration. Specific nutrients such as glutamine (the primary fuel for enterocytes), zinc, vitamin A, and short-chain fatty acids (SCFAs) support mucosal healing. In severe short bowel syndrome, parenteral nutrition (intravenous feeding) may be required.

Pharmacological Therapy

Teduglutide, a GLP-2 analogue, is an approved medication for promoting intestinal adaptation in short bowel syndrome. It stimulates mucosal proliferation and improves the absorptive capacity of the remaining small intestine.

Treatment of the Underlying Condition

For inflammatory conditions such as celiac disease (gluten-free diet) or Crohn's disease (immunosuppressive therapy), treating the underlying cause is the fundamental prerequisite for successful regeneration.

Probiotics and the Microbiome

The intestinal microbiome significantly influences the regeneration of the intestinal mucosa. Probiotic supplements and a microbiome-friendly diet can support the healing process.

References

1. Stappenbeck TS, Mills JC. - Molecular gastroenterology of intestinal stem cells. - Cell Stem Cell, 2021.
2. Jeppesen PB et al. - Teduglutide reduces need for parenteral support in patients with short bowel syndrome. - Gastroenterology, 2012; 143(6):1473-1481.
3. World Health Organization (WHO) - Nutritional Management of Intestinal Failure - WHO Technical Report, Geneva, 2020.